- Home
- SERA vs UCL Comparison
SERA vs UCL Comparison
Compare SERA & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERA
- UCL
- Stock Information
- Founded
- SERA 2008
- UCL 2014
- Country
- SERA United States
- UCL Hong Kong
- Employees
- SERA N/A
- UCL N/A
- Industry
- SERA Precision Instruments
- UCL Telecommunications Equipment
- Sector
- SERA Health Care
- UCL Consumer Discretionary
- Exchange
- SERA Nasdaq
- UCL Nasdaq
- Market Cap
- SERA 70.4M
- UCL 70.6M
- IPO Year
- SERA 2021
- UCL 2020
- Fundamental
- Price
- SERA $2.45
- UCL $1.83
- Analyst Decision
- SERA
- UCL
- Analyst Count
- SERA 0
- UCL 0
- Target Price
- SERA N/A
- UCL N/A
- AVG Volume (30 Days)
- SERA 808.6K
- UCL 59.0K
- Earning Date
- SERA 08-06-2025
- UCL 08-13-2025
- Dividend Yield
- SERA N/A
- UCL N/A
- EPS Growth
- SERA N/A
- UCL N/A
- EPS
- SERA N/A
- UCL 0.09
- Revenue
- SERA $115,000.00
- UCL $92,256,000.00
- Revenue This Year
- SERA $390.13
- UCL $6.09
- Revenue Next Year
- SERA $440.54
- UCL $7.01
- P/E Ratio
- SERA N/A
- UCL $20.05
- Revenue Growth
- SERA N/A
- UCL 7.65
- 52 Week Low
- SERA $1.37
- UCL $0.80
- 52 Week High
- SERA $9.13
- UCL $3.30
- Technical
- Relative Strength Index (RSI)
- SERA 53.40
- UCL 54.00
- Support Level
- SERA $1.82
- UCL $1.79
- Resistance Level
- SERA $4.09
- UCL $1.99
- Average True Range (ATR)
- SERA 0.38
- UCL 0.19
- MACD
- SERA 0.13
- UCL -0.03
- Stochastic Oscillator
- SERA 36.68
- UCL 15.38
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.